Back to Conference page
UICC World Cancer Congress 2006
Bridging the Gap: Transforming Knowledge into Action
July 8-12, 2006, Washington, DC, USA
Lung cancer is currently the leading cause of cancer deaths in both men and women in the United States, causing more deaths (163,150) than the next four most common cancers combined (colon - 56,290, breast - 40,870, and prostate - 31,800, pancreas - 30,350). Worldwide, approximately one to two million people die of this disease each year. The expected 5-year survival for all patients diagnosed with lung cancer is 15%. Little progress has been made in the successful treatment of this disease as the 5 year survival was 13% in 1974. A number of promising new diagnostic and treatment modalities, however, have been introduced that may offer potential improvements in survival.
Methods: The ACCP commissioned a review of existing lung cancer guidelines, systematic reviews and meta-analyses, and primary studies of designated topic areas. Evidence tables were produced and used to develop the guideline recommendations. The writing panel was an international group of over 80 lung cancer experts, representing seven specialties and thirteen medical, nursing, and patient advocacy associations.
Results: The guidelines were published in CHEST 2003; 123(1 suppl): 1s-337s, providing recommendations for screening, diagnosis and treatment of lung cancer. This session will review the treatment recommendations for non small cell and small cell lung cancer.
See more of Evidence-Based Guidelines for Lung Cancer Diagnosis and Treatment
See more of Cancer Research, Detection and Treatment
See more of The UICC World Cancer Congress 2006